|
Chi-Chung Chan, Ph.D.
Vice President of Biology, Head of Oncology
Over 26 years' experience of drug discovery in pharmacology, formerly Senior Investigator at Merck Frosst Center for Therapeutic Research, a subsidiary of Merck and Co. BSc. in Biology from the Chinese University of Hong Kong. Ph.D. in Pharmacology from University of Ottawa. postdoctoral fellowship at the National Research Council of Canada.
|
Mingli Chen, MD, MS, DABT
Vice President of Toxicology Services
Over 14 years’ experience in safety assessment with Pfizer, Novartis, Abbott and MPI Research. Formerly Vice President of Research and Testing Facility Manager at MPI/Medicilon Preclinical Research in Shanghai. American Board-certified toxicologist, M.S. in toxicology from University of Arizona and M.D. from Western China University of Medical Sciences.
|
Minzhang Chen, Ph.D.
Vice President, Process R&D and Manufacturing
Over 12 years’ experience in Process R&D and API Manufacturing, formerly Director of Technical Operations at Vertex Pharmaceuticals Inc. Ph.D. in Synthetic Organic Chemistry from University of Minnesota.
|
|
Robert Coldreck, RQAP-GLP
Vice President of GLP Quality Assurance
Formerly Director of Laboratory and Preclinical Quality Assurance (QA) North America and Asia for Novartis with over 36 years’ experience in research and Good Laboratory Practice Quality Assurance. B.S. in Biology from Fairleigh Dickinson University.
|
Xiao Feng
Vice President of Biological Platform Technology
Over 20 years’ experience in therapeutic antibody drug discovery and about 10 years’ clinic practice experience; worked as CEO at Beijing ABCO Pharmaceuticals Co. Ltd., Vice President at GenScript USA Inc., Director at Lexicon Pharmaceuticals Inc., and Senior Manager at Amgen (previous Abgenix) Inc.; M. D. in Biochemistry and Molecular Biology from Beijing Medical University.
|
Eugene Gong, Ph.D.
Vice President, Analytical R&D
Formerly Core Team Manager/Associate Principal Scientist in Pharmaceutical R&D of Forest Laboratories, Boehringer Ingelheim Pharmaceuticals and Wyeth Pharmaceuticals with over 12 years’ product development experience. Ph.D. from New York University.
|
|
Tao Guo, Ph.D.
Vice President of Medicinal Chemistry
Over 19 years’ experience in organic/medicinal chemistry, formerly Director of Chemistry at Pharmacopeia. B.S. in Chemistry from Peking University, Ph.D. in Organic Chemistry from Columbia University, and postdoctoral fellow in Bioorganic Chemistry at UC Berkeley.
|
Deepak Hegde, Ph.D.
Vice President of Formulation Development Services
Over 12 years' experience in formulation development and technical transfers in different positions across Rhone Poulenc, Novartis and USV. Ph.D. in Biopharmaceutics and Pharmacokinetics from University of Bombay.
|
Jane Lin
Vice President, Regulatory Affairs and Clinical Development
Over 14 years’ experience in the pharmaceutical industry. Formerly Medical Director in Merck Sharp & Dohme and Baxter responsible for regulatory affairs, clinical research, medical affairs and pharmacovigilance in mainland China and Hong Kong. M.D. from Xi’an Jiaotong University and M.P.H. from Shanghai Jiaotong University.
|
|
Linus Lin, Ph.D.
Vice President of Operation and Chemistry, Global Head of Chemistry Technology and Services
Over 10 years of experience in the field of synthetic chemistry and in building high performance teams; worked at Merck as the Global Chemistry Operations Lead; successfully delivered 7 preclinical candidates with one completed PhIII study; BS from Peking University, PhD from University of Wisconsin, and NIH postdoctoral fellow at Harvard University under the direction of Nobel laureate Prof EL Corey.
|
Henry Lu,Ph.D.
Vice President of Infectious Disease Research
Over 20 years’ experience in biological research and pharmaceutical industry. Formerly Adjunct Associate Professor at the University of California San Francisco, Senior Director of Infectious Diseases at Rigel Pharmaceuticals Inc. and Principle Scientist at Chiron Corporation (now Novartis). B.S. from Fudan University, Ph.D. from the Shanghai Institute of Biochemistry, Academia Sinica, and postdoctoral fellow at the State University of New York at Stony Brook with Prof. Eckard Wimmer.
|
Qiang Lu, Ph.D.
Vice President of Biology, Head of Discovery Technologies & NPII (Neuroscience, Pain, Inflammation, Immunology)
Over 20 years' experience in biological research and pharmaceutical industry, formerly Principal Scientist/Team Leader at Wyeth and Functional Head at Novartis. Ph.D. in Biochemistry from Brandeis University and postdoctoral fellow at Tufts Medical School in Boston.
|
|
Rujian Ma, Ph.D.
Vice President of Synthetic Chemistry
Over 16 years' experience in organic synthesis and in training new fellow scientists. Ph.D. in Pharmaceutical Sciences from the Faculty of Pharmaceutical Sciences, the University of Tokushima.
|
Naruhito Masai, Ph.D.
Vice President of Business Development for Japan and Specified Region
Formerly General Manager of Global Sales at Sumika Fine Chemicals with over 30 years' industry experience. Ph.D. from Tokyo University.
|
Steve Mason
Vice President, Operations, Preclinical Services
Over 17 years' experience in the CRO industry, in Europe (Huntingdon Life Sciences), North America and Asia (Charles River Laboratories). Formerly Scientific Director of Safety Pharmacology at Charles River Montreal and Director In Vivo Sciences and Site Director at Charles River Shanghai. M.Sc. in Toxicology from RMIT University in Australia.
|
|
Gonghua Pan
Vice President of Operation
Head of Program Management Office
Formerly Director and Head of Asia Research operation at Pfizer, with over 16 years’ drug discovery, outsourcing management and continuous improvement experiences at Pharmacopeia and Pfizer. Ph.D. from University of Wisconsin-Madison, MBA from School of Management at Yale University and B.S. from Peking University.
|
Yifeng Shi
Vice President of Operations
Waigaoqiao Site Head
Compliance Officer of WuXi AppTec China Region
Over 18 years’ experience in organic synthesis, worked at Shanghai Institute of Organic Chemistry and GLSynthesis. B.S. from Shanghai University of Science and Technology.
|
Neng Yang Shih, Ph.D.
Chairman of Discovery Program Review
Over 25 years’ experience in medicinal chemistry and drug discovery. Formerly Executive Director and Head of Chemistry at Merck’s Cambridge site. Ph.D. in Organic Chemistry from the University of Illinois at Chicago and post-doctoral fellow at Columbia University and Harvard University.
|
|
Hongye Sun, Ph.D.
Vice President of Operation and Technology Platform, and Chief Operation Officer, WuXi Genomic Center
Over 10 years' experience in DNA sequencing technology research and development at Applied Biosystems (now Life Technologies Corp). Led a multi-disciplinary team to develop real-time single molecule DNA sequencing technologies. Ph.D. from Peking University and post-doctoral fellow at Harvard University and University of Kansas.
|
Jason Wan, Ph.D. and MBA
Vice President, Pharmaceutical Science
Over 21 years’ experience in formulation and drug delivery R&D, formerly Sr. Fellow and Head of Exploratory Formulation Development for Schering Plough/Merck. Prior employers include Pfizer, Alza / JNJ, and Syntex / Roche. Ph.D in Pharmaceutical Sciences from University of Southern California and MBA from University of Michigan.
|
Chengde Wu, Ph.D.
Vice President, Medicinal Chemistry
Inventor of Thelin® and formerly Director of Medicinal Chemistry at Encysive Pharmaceuticals with 15 years’ experience in US biopharmaceutical drug discovery. Ph.D. in Organic Chemistry from Columbia University with Prof. Gilbert Stork.
|
|
Chun Wu, Ph.D.
Vice President of Biological Reagent Products and Services
Formerly founder and CEO of Abgent. Over 20 years’ experience in research products/services and diagnostics at New England Biolabs and BD PharMingen. Ph.D. in Neurobiology from University of Manchester, U.K.
|
Jinsong Xing, Ph.D.
Vice President of Bioanalytical Service
Over 10 years' experience in bioanalytical area, formerly worked at BASF and then Bristol-Myers Squibb. Ph.D. from Rutgers University.
|
Jerry Xu, Ph.D.
Vice President of GMP QA and Regulatory Affairs
Over 20 years’ experience in the pharmaceutical industry. Formerly CMC reviewer at FDA, Director of Process Development at Pharmaceutics International, Senior Manager of Global Technical Support at Wyeth, founder of Shanghai Fleecon Biomedical Inc. Ph.D. from Northeastern University.
|
Trabue D. Bryans
Vice President
General Manager of Atlanta Operations
Over 25 years' experience in medical device industry, Member of the standards board of Association for the Advancement of Medical Instrumentation. B.S. from University of Georgia, M(ASCP) certification in Microbiology from Medical College of Georgia.
|
Hui Cai, Ph.D.
Vice President of Corporate Alliances
Over 11 years’ experience in drug discovery (Johnson & Johnson PRD), strategic planning, business development, and portfolio management; formerly President of Inflexion BioPartners and Vice President of Corporate Development at HUYA Bioscience. B.S. and M.S. in Chemistry from Peking University, Ph.D. from The Scripps Research Institute, and M.B.A. from UCSD Rady School of Management.
|
Bill Farley
Vice President, Key Accounts
Over 30 years’ experience in Sales and Marketing with the last 15 years’ in Business Development. During the last 10 years at ChemDiv, Inc as the Vice President of BD. Held positions in management and sales for Pharmacia, Biacore, and Trega and began a career in Drug Discovery at Johnson and Johnson. Hold a B.S. in Chemistry from SUNY Oswego and has taken a variety of graduate course at Rutgers University and UC Irvine.
|
|
 Joseph V. Hughes, Ph.D.
Vice President of Testing Services for Philadelphia Facility
Over 26 years' experience in molecular biology and virology including 8 years' drug and vaccine research development experience at Merck. Ph.D. in Microbiology from Northwestern University.
|
Scott Kramer
Vice President of Finance and Administration, U.S. Operations
Over 10 years’ experience at Medtronic in senior finance roles supporting operations, R&D, sales, and corporate accounting. Formerly employed with Intel, Western Pioneer and Ernst & Young. MBA in Finance from the Wharton School, University of Pennsylvania, and a licensed CPA.
|
Alan Moore
Vice President of Testing and Cell Services
Thirty years of experience in biologics safety testing and contract manufacturing services. Operations, regulatory, quality and business management responsibilities with Microbiological Associates (BioReliance), Primedica (Genzyme Corp.) and Althea Technologies. B.S., Research Option in Biological Sciences, West Virginia University.
|
|
Lisa Olson
Vice President of Testing and Service Development
One of the original laboratory directors at AppTec, U.S. Expert and Co-Chair to ISO Technical Advisory Group on Cytoxicity. B.S. in Microbiology from University of Minnesota.
|
Teri Tanquist
Vice President of Process Improvement and Operations (US)
Over 10 years’ experience in operations, with five years in medical device industry. Held senior positions at Medtronic including the areas of Continuous Improvement, Planning, and Manufacturing. B.S. in Productions and Operations from Winona State University.
|
